Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HHS Office of Inspector General (OIG)
Regulatory
OIG: Medicare Part D plans spent millions on ineligible drugs
Medicare Part D plans made millions in payments for drugs that were ineligible under the program, according to a new federal audit.
Paige Minemyer
Sep 3, 2026 1:40pm
HHS refers providers, PBMs to DOJ for gender care billings
Aug 13, 2026 1:30pm
OIG: States can boost oversight of Medicaid MCO fraud referrals
Jul 21, 2026 5:13pm
OIG warns about maternal health 'ghost networks' in Medicaid
Jun 17, 2026 2:00pm
OIG: Frequent MA prior auth denials for LTCH, inpatient rehab
Jun 11, 2026 1:45pm
The watchdog overseeing the integrity of HHS programs
Jun 3, 2026 9:44am
